Post-earnings recap
Reported
Thu, Nov 12, 2015
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Collegium Pharmaceutical reported a larger-than-expected loss per share, which contributed to a decline in its stock price by 5.84%. The lack of revenue figures and management commentary leaves uncertainty about the company's performance and future outlook. Investors may be cautious as they await more information.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.46 | N/A | -53.33% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.